Mind Medicine (MindMed) Inc.

    Mind Medicine (MindMed) Inc.

    NNEO:MMED
    - -
    CAD
    - -
    - -
    Mind Medicine (MindMed) Inc.
    NEO:MMED
    (Cboe Canada)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -1.91
    -3.4
    -1.84
    -2.44
    - -
    - -
    Basic EPS, GAAP
    -1.33
    -1.67
    -1.62
    -1.64
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -2.51
    -5.03
    -6.3
    -7.41
    - -
    - -
    Book Value per Share
    4.27
    4.56
    4.13
    1.47
    - -
    - -
    Tangible Book Value per Share
    18
    27
    31
    39
    - -
    - -
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    3
    3
    3
    1
    - -
    Depreciation Expense
    -34
    -93
    -57
    -96
    -109
    -168
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    79
    127
    128
    72
    243
    150
    Working Capital
    - -
    - -
    - -
    14
    22
    40
    LT Debt
    76
    152
    151
    78
    241
    131
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    22
    41
    40
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    76
    76
    77
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    222
    189
    216
    Cash, Cash Equivalents & STI
    212
    183
    209
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    30
    38
    65
    Payables & Accruals
    9
    14
    20
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    209.02%
    Free Cash Flow
    - -
    - -
    22.94%
    Net Income, GAAP
    - -
    - -
    13.52%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.65
    -0.76
    -0.45
    - -
    -2.44
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business